scutellarin has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Q; Gao, Z; Gu, J; Lei, F; Liu, F; Niu, P; Peng, J; Wang, Y; Zhao, J | 1 |
| Liu, Y; Wang, Z; Yang, N; Zhang, Y; Zhao, Y | 1 |
2 other study(ies) available for scutellarin and Colorectal Neoplasms
| Article | Year |
|---|---|
Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway.
Topics: Animals; Apoptosis; Cell Proliferation; Colorectal Neoplasms; Mice; Mice, Nude; Neoplastic Processes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2023 |
Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway.
Topics: Antineoplastic Agents, Phytogenic; Apigenin; Apoptosis; Cell Proliferation; Colon; Colorectal Neoplasms; Glucuronates; HCT116 Cells; Humans; Rectum; Scutellaria; Signal Transduction; Tumor Suppressor Protein p53 | 2017 |